CTI Biopharma reported $733K in Stock for its fiscal quarter ending in December of 2022.



Stock Change Date
Baxter International USD 2.32B 84M Mar/2026
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Eli Lilly USD 14.53B 785M Mar/2026
Geron USD 133.29M 16.65M Mar/2026
Incyte USD 115.62M 14.56M Mar/2026
Novartis USD 6.29B 17M Mar/2026
Novartis USD 6.42B 114M Sep/2025